Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells

por Van Sciver, Nicholas, Ohashi, Makoto, Pauly, Nicholas P., Bristol, Jillian A., Nelson, Scott E., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2021

Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ

por Singh, Deo R., Nelson, Scott E., Pawelski, Abigail S., Kansra, Alisha S., Fogarty, Stuart A., Bristol, Jillian A., Ohashi, Makoto, Johannsen, Eric C., Kenney, Shannon C.
Publicado 2023

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model

por Romero-Masters, James C., Ohashi, Makoto, Djavadian, Reza, Eichelberg, Mark R., Hayes, Mitch, Bristol, Jillian A., Ma, Shidong, Ranheim, Erik A., Gumperz, Jenny, Johannsen, Eric C., Kenney, Shannon C.
Publicado 2018

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

por Bilger, Andrea, Plowshay, Julie, Ma, Shidong, Nawand ar, Dhananjay, Barlow, Elizabeth A., Romero-Masters, James C., Bristol, Jillian A., Li, Zhe, Tsai, Ming-Han, Delecluse, Henri-Jacques, Kenney, Shannon C.
Publicado 2017

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells

por Van Sciver, Nicholas, Ohashi, Makoto, Nawandar, Dhananjay M., Pauly, Nicholas P., Lee, Denis, Makielski, Kathleen R., Bristol, Jillian A., Tsao, Sai Wah, Lambert, Paul F., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2021

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mi...

por Li, Chunrong, Romero-Masters, James C., Huebner, Shane, Ohashi, Makoto, Hayes, Mitchell, Bristol, Jillian A., Nelson, Scott E., Eichelberg, Mark R., Van Sciver, Nicholas, Ranheim, Erik A., Scott, Rona S., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2020

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection

por Bristol, Jillian A., Djavadian, Reza, Albright, Emily R., Coleman, Carrie B., Ohashi, Makoto, Hayes, Mitchell, Romero-Masters, James C., Barlow, Elizabeth A., Farrell, Paul J., Rochford, Rosemary, Kalejta, Robert F., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2018

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells

por Bristol, Jillian A., Brand, Joshua, Ohashi, Makoto, Eichelberg, Mark R., Casco, Alejandro, Nelson, Scott E., Hayes, Mitchell, Romero-Masters, James C., Baiu, Dana C., Gumperz, Jenny E., Johannsen, Eric C., Dinh, Huy Q., Kenney, Shannon C.
Publicado 2022

Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes

por Singh, Deo R., Nelson, Scott E., Pawelski, Abigail S., Cantres-Velez, Juan A., Kansra, Alisha S., Pauly, Nicholas P., Bristol, Jillian A., Hayes, Mitchell, Ohashi, Makoto, Casco, Alejandro, Lee, Denis, Fogarty, Stuart A., Lambert, Paul F., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2022

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

por Romero-Masters, James C., Huebner, Shane M., Ohashi, Makoto, Bristol, Jillian A., Benner, Bayleigh E., Barlow, Elizabeth A., Turk, Gail L., Nelson, Scott E., Baiu, Dana C., Van Sciver, Nicholas, Ranheim, Erik A., Gumperz, Jenny, Sherer, Nathan M., Farrell, Paul J., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2020